Importantly, inactivation of CtBP2 is the critical defect in the pathogenesis of obesity leading to metabolic inflexibility while activation of CtBP2 can be a therapeutic approach for the obesity-induced metabolic diseases. This evidence concerns the gene CTBP2 and obesity disorder.